Molecula Maxima · raw details

Synthetic Biology Platform for Genetic Engineering · Founded 2015

inactive Pre-Funding ← back to profile

Highlights

Profile claimed by owner

About

Synthetic Biology Platform for Genetic Engineering

Molecula Maxima is developing a programming environment for the creation of new genetically modified organisms and drugs. Its goal is to make the synthetic biology field accessible to software developers and engineers. Engineers can use Molecula Maxima's Synthetic bioprogramming language and the Cytostudio IDE to design, debug, compile, and optimize chemically synthesized genes.

Identity

NameMolecula Maxima
Slugmolecula-maxima
Type / kindstartup
Crunchbase IDmolecula-maxima
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNHch4oJDA

Status

Statusinactive
Status reasonNon Active, Dec 2017
Last update2026-05-17

Location

HQ country codeIL
HQ addressIsrael

Web & social

LinkedInhttps://www.linkedin.com/company/10381520
Twitter / Xhttps://twitter.com/moleculamaxima
Facebookhttps://www.facebook.com/moleculamaxima

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesLife SciencesPharmaceuticals
Business models
B2B
Tags
software-applicationsgenetic-engineeringgenomicsbioinformaticslaboratoriespharma-companies

Funding

Total raised—
Current stagePre-Funding

Raw source document

Show full JSON (0 KB) 
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}